Select to adjust search filters (mandatory)
SHS NOVATURAS ORD
AB NOVATURAS PVA, LT0000131872

Date

SE trades

Over-the-counter

DVP No. of securities units Total nominal value Turnover(EUR) DVP FOP No. of securities units Total nominal value
2025 May 35 3,676 5,339 1 230
2025 April 677 93,784 141,951
2025 March 2,136 693,629 1,055,741 2 4 58,548
2025 February 971 134,524 202,406
2025 January 904 129,474 198,860
2024 December 877 166,102 241,721 1 100
2024 November 856 107,223 160,957 2 900
2024 October 917 79,613 125,878 2 900
2024 September 999 84,435 132,159 1 324
2024 August 2,056 182,443 305,311 1 1,100
2024 July 1,902 211,722 424,363 1 149
2024 June 1,382 121,021 280,547 2 2,000
2024 May 2,513 235,517 616,455
2024 April 1,750 159,486 487,745 1 3 15,570
2024 March 2,177 239,806 787,922 1 20,000
2024 February 1,467 183,228 642,003 7 469,646
2024 January 1,316 186,422 639,681 16 1 88,644
2023 December 1,596 248,363 837,504 4 3 412,000
2023 November 1,048 98,367 321,489 1 5,112
2023 October 880 50,262 161,941 2 1,020
2023 September 1,347 209,313 694,531
2023 August 985 142,310 476,623 1 30,000
2023 July 1,105 84,048 293,043
2023 June 1,480 159,060 522,711 2 270
2023 May 550 42,125 131,788
2023 April 752 58,464 185,052 1 740,702
2023 March 1,749 168,900 541,694
2023 February 1,509 201,669 651,980 57 1 51,200
2023 January 1,410 223,269 681,104 81 2 69,251
2022 December 797 74,452 224,163 25 10,182
2022 November 1,337 106,855 314,013 17 11,439
2022 October 801 54,872 145,252
2022 September 1,701 99,617 282,491 2 1,167
2022 August 1,726 159,674 536,977 2 6,714
2022 July 1,033 54,098 186,224 2 20,200
2022 June 1,143 68,993 257,246 6 80,000
1 2 3

Please note that settlement statistics part of the website only contains information about settled transactions starting from September 18, 2017 for Estonian, Latvian, and Lithuanian markets, and starting from August 24, 2020 - for Estonian, Latvian, Lithuanian and Icelandic markets.

The use of information contained on Nasdaq CSD website is governed by the Terms and Conditions. The use of statistical data for commercial purposes is the subject to additional fees. Please contact csd@nasdaq.com to receive further information.